Endothelin-1: An interesting peptide or an important mediator in pulmonary diseases?

Pulmonary Pharmacology and Therapeutics

Volumn 11, Issue 2-3, 1998, Pages 141-146

  Hay, D W P ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST;

ALLERGIC RHINITIS; ASTHMA; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; HUMAN; LUNG; LUNG DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN SYNTHESIS; PULMONARY HYPERTENSION; TISSUE DISTRIBUTION;

EID: 0032056053     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1998.0128     Document Type: Conference Paper

References (75)

1. 1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
2. 2. Giaid A, Polak J M, Gaitonde V, Hamid Q A, Moscoso G, Legon S, Uwanogho D, Roncalli M, Shinmi O, Sawamura T, Kimura S, Yanagisawa M, Masaki T, Spirngall D R. Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lung. Am J Respir Cell Mol Biol 1991; 4: 50-58.
3. 3. Ehrenreich H, Anderson R W, Fox C H, Rieckman P, Hoffmann G S, Travis W D et al. Endothelins, peptides with potent properties, are produced by human macrophages. J Exp Med 1990; 172: 1741-1748.
4. 4. McCumber M W, Ross C A, Glaser B M, Snyder S H. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 1989; 86: 7285-7289.
5. 5. Mullol J, Chowdhury B A, White M V, Ohkubo K, Rieves R D, Baraniuk J, Hausfield J N, Shelhamer J H, Kaliner M A. Endothelin in human nasal mucosa. Am J Respir Cell Mol Biol 1993; 8: 393-402.
6. 6. Pons F, Touvay C, Lagente V, Mencia-Huerta J M, Braquet P. Involvement of a phosphoramidon-sensitive endopeptidase in the processing of big endothelin-1 in the guinea-pig. Eur J Pharmacol 1992; 217: 65-70.
7. 7. Sawamura T, Shinmi O, Kishi N, Sugita Y, Yanagiswaw M, Goto K et al. Characterization of phosphoramidon-sensitive metalliproteinases with endothelin-converting enzyme activity in porcine lung membrane. Biochim Biophys Acta 1993; 1161: 295-302.
8. 8. Black P M, Ghatei M A, Takahashi K, Bretherton-Watt D, Krausz T, Dollery C T. Formation of endothelin by cultured airway epithelial cells. FEBS Letts 1989; 255: 129-132.
9. 9. Endo T, Uchida Y, Matsumoto H, Suzuki N, Nomura A, Hirata F, Hasegawa S. Regulation of endothelin-1 synthesis in cultured pig airway epithelial cells by various cytokines. Biochem Biophys Res Commun 1992; 186: 1594-1599.
10. 10. Mattoli S, Mezzett M, Riva G, Allegra L, Fasoli A. Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Mol Biol 1990; 3: 145-151.
11. 11. Hay D W P. Guinea-pig tracheal epithelium and endothelin. Eur J Pharmacol 1989; 171: 241-245.
12. 12. Yamaguchi T, Kohrogi H, Kawano O, Ando M, Araki S. Neutral endopeptidase inhibitor potentiates endothelin-1-induced airway smooth muscle contraction. J Appl Physiol 1992; 73: 1108-1113.
13. 13. Rimar S, Gillis C N. Differential uptake of endothelin-1 by the coronary and pulmonary circulations. J Appl Physiol 1992; 73: 557-562.
14. B receptors in rat. Biochem Biophys Res Commun 1994; 199: 1461-1465.
15. 15. Masaki T, Yanagisawa M, Goto K. Physiology and pharmacology of endothelins. Med Res Rev 1992; 12: 391-421.
16. 16. Goldie R G, Knott P G, Carr M J, Hay D W P, Henry P J. The endothelins in the pulmonary system. Pulmon Pharmacol 1996; 9: 69-93.
17. 17. Goldie R G, Henry P J, Knott P G, Self G J, Luttmann M A, Hay D W P. Endothelin-1 receptor density, distribution and function in human isolated asthmatic airways. Am J Respir Crit Care Med 1995; 152: 1653-1658.
18. 18. Henry P J, Rigby P J, Self G J, Preuss J M, Goldie R G. Relationship between endothelin-1 binding site densities and constrictor activities in human and animal airway smooth muscle. Br J Pharmacol 1990; 100: 786-792.
19. 19. Power R F, Wharton J, Zhao Y, Bloom S R, Polak J M. Autoradiographic localization of endothelin-1 binding sites in the cardiovascular and respiratory systems. J Cardiovasc Pharmacol 1989; 13 (Suppl. 5): S50-S56.
20. 20. Knott P G, D'Aprile A C, Henry P J, Hay D W P, Goldie R G. Receptors for endothelin-1 in asthmatic human peripheral lung. Br J Pharmacol 1995; 114: 1-3.
21. 21. Fukuroda T, Kobayashi M, Ozaki S, Yano M, Miyauchi T, Onizuka M, Sugishita Y, Goto K, Nishikibe M. Endothelin receptor subtypes in human versus rabbit pulmonary arteries. J Appl Physiol 1994; 76: 1976-1982.
22. 22. Hay D W P, Henry P J, Goldie R G. Endothelin and the respiratory system. Trends Pharmacol Sci 1993; 14: 29-32.
23. 23. Michael J R, Markewitz B A. Endothelins and the lung. Am J Respir Crit Care Med 1996; 154: 555-581.
24. B receptor subtype. J Pharmacol Exp Therap 1998; 284: 669-677.
25. 25. Brink C, Gillard V, Roubert P, Mencia-Huerta J M, Chabrier P E, Braquet P, Verley J. Effects and specific binding sites of endothelin in human lung preparations. Pulmon Pharmacol 1991; 4: 54-59.
26. B receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchus. Br J Pharmacol 1996; 117: 995-999.
27. 27. Williams D L Jr, Jones K L, Pettibone D J, Lis E V, Clineschmidt B V. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 1991; 175: 556-561.
28. 28. Chalmers G W, Little S A, Patel K R, Thompson N C. Endothelin-1-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1997; 156: 382-388.
29. 29. Tomlinson P R, Wilson J W, Stewart A G. Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br J Pharmacol 1994; 111: 641-647.
30. A receptor-mediated phenomenon. Br J Pharmacol 1996; 118: 191-197.
31. 31. Peacock A J, Dawes K E, Shock A, Gray A J, Reeves J T. Endothelin-1 and endothelin-3 induces chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 1992; 7: 492-499.
32. 32. Murlas C G, Gulati A, Singh G, Najmabadi F. Endothelin-1 stimulates proliferation of normal airway epithelial cells. Biochem Biophys Res Commun 1995; 212: 953-959.
33. 33. Marini M, Carpi S, Bellini A, Patalano F, Mattoli S. Endothelin-1 induces increased fibronectin expression in human bronchial epithelial cells. Biochem Biophys Res Commun 1996; 220: 896-899.
34. 34. Helset E, Sidnes T, Seljelid R, Konoski Z S. Endothelin-1 stimulates human myocytes in vitro to release TNF-α, IL-β and IL-6. Mediators Inflamm 1993; 2: 417-422.
35. 35. Egger D, Geuenich S, Denzlinger C, Schmitt E, Mailhammer R, Ehrenheich H, Dormer P, Hultner L. IL-4 renders mast cells functionally responsive to endothelin-1. J Immunol 1995; 154: 1830-1837.
36. 36. Nagase T, Fukuchi Y, Jo C, Teramoto S, Uejima Y, Ishida K et al. Endothelin stimulates arachidonate 15-lipoxygenase and oxygen radical formation in the rat distal lung. Biochem Biophys Res Commun 1990; 168: 485-489.
37. 37. Ninomiya H, Yu X Y, Hasegawa S, Spannhake E W. Endothelin-1 induces stimulation of prostaglandin synthesis in cells obtained from canine airways by bronchoalveolar lavage. Prostaglandins 1992; 43: 401-411.
38. 38. Bath PMW, Mayston S A, Martin J F. Endothelin and PDGF do not stimulate peripheral blood monocyte chemotaxis, adhesion to endothelium and superoxide production. Exp Cell Res 1990; 187: 339-342.
39. 39. Fujitani Y, Trifilieff A, Tsuyuki S, Coyle A J, Bertrand C. Endothelin receptor antagonists inhibit antigen-induced lung inflammation in mice. Am J Respir Crit Care Med 1997; 155: 1890-1894.
40. 40. Andersson S E, Zackrisson C, Behrens K, Hemsèn A, Forsberg K, Linden M, Lundberg J M. Effect of allergen provocation on inflammatory cell profile and endothelin-like immunoreactivity in guinea-pig airways. Allergy 1995; 50: 349-358.
41. 41. Finsnes F, Skj-nsberg O H, T-nnessen T, NÊss O, Lyberg T. Endothelin production and effects of endothelin antagonism during experimental airway inflammation. Am J Respir Crit Care Med 1997; 155: 1404-1412.
42. 42. Macquin-Mavier I, Levame M, Istin N, Harf A. Mechanism of endothelin-mediated bronchoconstriction in the guinea pig. J Pharmacol Exp Therap 1989; 250: 740-745.
43. 43. Boichot E, Carrè C, Lagente V, Pons F, Mencia-Huerta J M, Braquet P. Endothelin-1 (ET-1) and bronchial hyperresponsiveness in the guinea-pig. J Cardiovasc Pharmacol 1991; 17 (Suppl. 7): S329-S331.
44. 44. Pons F, Boichot E, Lagente V, Touvay C, Mencia-Huerta J M, Braquet P. Role of endothelin in pulmonary function. Pulmon Pharmacol 1992; 5: 213-219.
45. B) receptor-activated potentiation of cholinergic nerve-mediated contraction in human bronchus. Br J Pharmacol 1996; 118: 1873-1874.
46. 46. Shimura S, Ishihara H, Satoh M, Masuda T, Nagaki N, Sasaki H, Takishima T. Endothelin regulation of mucus glycoprotein secretion from feline tracheal submucosal glands. Am J Physiol 1992; 262: L208-L213.
47. 47. Hay D W P, Hubbard W C, Luttmann M A, Undem B J. Endothelin receptor subtypes in human and guinea-pig pulmonary tissues. Br J Pharmacol 1993; 110: 1175-1183.
48. 48. McCulloch K M, MacLean M R. EndothelinB receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat. J Cardiovasc Pharmacol 1995; 26: S169-S176.
49. A receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 1993; 9: 429-433.
50. 2+]i, protein phosphorylation, and O2-ï production in human alveolar macrophages. Am J Physiol 1991; 261: L478-L484.
51. 51. Wright C D, Cody W L, Dunbar J B Jr, Doherty A M, Hingorani G P, Rapundalo S T. Characterization of endothelins as chemoattractants for human neutrophils. Life Sci 1994; 21: 1633-1641.
52. 52. Halim A, Kanayama N, Maradny E E, Maehara K, Terao T. Activated neutrophil by endothelin-1 caused tissue damage in human umbilical cord. Thromb Res 1995; 77: 321-327.
53. 53. Wu T, Mullol J, Rieves R D, Logun C, Hausfield J, Kaliner M A, Shelhamer J H. Endothelin-1 stimulates eicosanoid production in cultured human nasal mucosa. Am J Respir Cell Mol Biol 1992; 6: 168-174.
54. 54. Riccio M A, Reynolds C J, Hay D W P, Proud D. Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals. Am J Respir Crit Care Med 1995; 152: 1757-1764.
55. 55. Springall D R, Howarth P H, Counihan H, Djukanovic R, Holgate S T, Polak J M. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet 1991; 337: 697-701.
56. 56. Redington A E, Springall D R, Ghatei M A, Lau L C K, Bloom S R, Holgate S T, Polak J M, Howarth P H. Endothelin in bronchoalveolar lavage fluid and its relation to airflow obstruction in asthma. Am J Respir Crit Care Med 1995; 151: 1034-1039.
57. 57. Chanez P, Vignola A M, Albat B, Springall D R, Polak J M, Godard P, Bousquet J. Involvement of endothelin in mononuclear phagocyte inflammation in asthma. J Allergy Clin Immunol 1996; 98: 412-420.
58. 58. Chalmers G W, Thomson L, Macleod K J, Dagg K D, McGinn B J, McCharry C, Patel K R, Thomson N C. Endothelin-1 levels in induced sputum samples from asthmatic and normal subjects. Thorax 1997; 52: 625-627.
59. 59. Kraft M, Beam W R, Wenzel S E, Zamora M R, O'Brien R F, Martin R J. Blood and bronchoalveolar lavage endothelin-1 levels in nocturnal asthma. Am J Respir Crit Care Med 1994; 149: 947-952.
60. 60. Redington A E, Springall D R, Meng Q H, Tuck A B, Holgate S T, Polak J M, Howarth P H. Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol 1997; 100: 544-552.
61. 61. Mattoli S, Soloperto M, Marini M, Fasoli A. Levels of endothelin in the bronchoalveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J Allergy Clin Immunol 1991; 88: 376-384.
62. 62. Aoki T, Kojima T, Ono A, Unishi G, Yoshijima S, Kameda-Hayashi N, Yamamoto C, Hirata Y, Kobayashi Y. Circulating endothelin-1 levels in patients with bronchial asthma. Annals Allergy 1994; 73: 365-369.
63. 63. Allen S W, Chatfield B A, Koppenhafer S A, Schaffer M S, Wolfe R R, Abman S H. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis 1993; 148: 519-522.
64. 64. Cernacek P, Stewart D J. Immunoreactive endothelin in human plasma: marked elevations in patients with cardiogenic shock. Biochem Biophys Res Commun 1989; 161: 562-567.
65. 65. Sofia M, Mormile M, Faraone S, Alifano M, Zofra S, Romano L et al. Increased endothelin-like immunoreactive material on bronchoalveolar lavage fluid from patients with bronchial asthma and patients with interstitial lung disease. Respiration 1993; 60: 89-95.
66. 66. Sokeir M O, Parè P, Wright J L. Relation of smoking to immunoreactive endothelin in the bronchoalveolar epithelial cells. Thorax 1994; 49: 786-788.
67. 67. Ferri C, Bellini C, DeAngelis C, DeSiati L, Perrone A, Properzi G, Santucci A. Circulating endothelin-1 concentrations in patients with chronic hypoxia. J Clin Pathol 1995; 48: 519-524.
68. 68. Furukawa K, Saleh D, Bayan F, Emoto N, Kaw S, Yanagiswaw M, Giaid A. Co-expression of endothelin-1 and endothelin-converting enzyme-1 in patients with chronic rhinitis. Am J Respir Cell Mol Biol 1996; 14: 248-253.
69. 69. Saleh D, Furukawa K, Tsao M-S, Maghazachi A, Corrin B, Yanagisawa M, Barnes P J, Giaid A. Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines. Am J Respir Cell Mol Biol 1997; 16: 187-193.
70. 70. Oparil S, Chen S J, Meng Q C, Elton T S, Yano M, Chen Y F. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am J Physiol 1995; 12: L95-L100.
71. 71. Underwood D C, Bochnowicz S, Osborn R R, Luttmann M A, Hay D W P. Non-peptide endothelin receptor antagonists X. Inhibition of endothelin-1 and hypoxia-induced pulmonary pressor responses in the guinea pig by the endothelin receptor antagonist, SB 217242. J Pharmacol Exp Therap 1997; 283: 1130-1137.
72. A-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am J Physiol 1995; 269: L690-L697.
73. 73. Chen S-J, Chen Y-F, Opgenorth T J, Wessale J L, Meng Q C, Durand J, DiCarlo V S, Oparil S. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. J Cardiovasc Pharmacol 1997; 29: 713-725.
74. 74. Nagase T, Kurihara H, Kurihara Y, Aoki T, Fukuchi Y, Yazaki Y, Ouchi Y Airway hyperresponsiveness to methacholine in mutant mice deficient in endothelin-1. Am J Respir Crit Care Med 1998; 157: 560-564.
75. 75. Warner T D, Allcock G H, Corder R, Vane J R. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol 1993; 110: 777-782.